Our data demonstrate that activating Notch3 signaling is sufficient to accelerate disease progression and increase ascites accumulation in a mouse model of ovarian cancer, ID8 IP2 in the peritoneal cavity. This evidence concerns the gene NOTCH3 and ovarian cancer.